Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Agonism of the FGFR1c-beta-Klotho complex, which induces receptor dimerization and subsequent activation of the intracellular tyrosine kinase domains, leading to downstream signaling through the MAPK/ERK and PI3K/Akt pathways [2, 14].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast growth factor 21–Fibroblast growth factor receptor 1c complex (FGF21–FGFR1c).